Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic.
van der Watt PJ, Chi A, Stelma T, Stowell C, Strydom E, Carden S, Angus L, Hadley K, Lang D, Wei W, Birrer MJ, Trent JO, Leaner VD.
van der Watt PJ, et al.
Mol Cancer Ther. 2016 Apr;15(4):560-73. doi: 10.1158/1535-7163.MCT-15-0052. Epub 2016 Feb 1.
Mol Cancer Ther. 2016.
PMID: 26832790